Aveo Capital Partners, LLC Cidara Therapeutics, Inc. Transaction History

Aveo Capital Partners, LLC

  • $910 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024
SELL
$0.68 - $0.97 $13,600 - $19,400
-20,000 Reduced 47.06%
22,502 $17,000
Q4 2021

Feb 11, 2022
BUY
$1.18 - $2.18 $23,600 - $43,600
20,000 Added 88.88%
42,502 $54,000
Q3 2021

Nov 12, 2021
BUY
$1.48 - $2.35 $33,302 - $52,879
22,502 New
22,502 $50,000

About Cidara Therapeutics, Inc.

CDTX Quotes by TradingView
  • Ticker CDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,075,696
  • Market Cap $1.63B
  • Description
  • Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...
More about CDTX
Track This Portfolio

Track Aveo Capital Partners, LLC Portfolio

Follow Aveo Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aveo Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aveo Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email